Published on: 06/02/2025
Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than the first.
first-mover advantage in reimbursementreimbursement strategy for medical devicespayer evidence requirementsMedTech reimbursement challengescomparative coverage thresholdsclinical trial evidenceCMS policyhealthcare payerscoverage approvalmarket accesscoding and paymentreal-world evidencemedical device innovationwhy it’s harder for new MedTech companies to get coveragehow to compete with an already reimbursed medical device